Phencyclidine pharmacokinetics and concentration-response relationships in the pigeon

Phencyclidine (PCP) pharmacokinetics and drug discrimination were examined in pigeons (n=6 in both groups) after intramuscular doses of 1.48 mg/kg. PCP absorption was rapid with maximum measured plasma concentrations ranging from 559 to 1450 ng/ml at 10–30 min after dosing, which corresponded to the...

Full description

Saved in:
Bibliographic Details
Published inPharmacology, biochemistry and behavior Vol. 35; no. 4; pp. 797 - 801
Main Authors Michael Owens, S., McMillan, D.E., Hardwick, William C., Wessinger, William D.
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.04.1990
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Phencyclidine (PCP) pharmacokinetics and drug discrimination were examined in pigeons (n=6 in both groups) after intramuscular doses of 1.48 mg/kg. PCP absorption was rapid with maximum measured plasma concentrations ranging from 559 to 1450 ng/ml at 10–30 min after dosing, which corresponded to the time of maximum PCP stimulus effects in the drug discrimination studies. The terminal elimination half-life was 0.88 hr (harmonic mean). Average values for the volume of distribution and total body clearance were 1.6 1/kg and 18.2 ml/min/kg, respectively. In the behavioral studies, pigeons discriminated PCP-like effects from about 2 min to 2 hr after dosing. An average value for response on the PCP-appropriate key and for PCP concentration at each time point from 2 min to 2 hr was calculated from the individual subject data. Least-squares linear regression analysis of these data showed a highly significant relationship between the ability to discriminate PCP and log PCP concentration (y = 103 x − 219, r 2 = .810, p<0.005). This analysis suggests PCP concentration is a good predictor of behavioral efficacy.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0091-3057
1873-5177
DOI:10.1016/0091-3057(90)90361-K